Humana is the second largest Medicare Advantage plan in the United States and one of the world's leading healthcare companies.
Humana is the second largest Medicare Advantage plan in the United States by enrollment, with approximately 5.2 million MA members, and a CenterWell health services platform covering primary care, home health, and pharmacy services for Medicare-aged populations. The company guided to at least $128 billion in 2025 consolidated revenue, growing approximately 8% year-over-year. Humana's strategic focus on Medicare Advantage and the senior population — approximately 95% of insurance segment revenues come from government-sponsored programs — creates concentrated exposure to CMS funding decisions, star rating outcomes, and medical cost trends in the senior population. The 2025 Medicare Advantage environment was characterized by elevated cost trends and membership losses that pressured industry margins.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and digital health platforms
• Latest products, programs, and service initiatives
• M&A and partnership activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management
Table of Contents
1. Executive Summary
2. Company Overview
3. Strategic Directions
4. Financial Performance
5. SWOT Analysis
6. Technological Know-How and Key Products
7. M&A and Partnerships
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Humana — Key Financial Metrics 2023-2025
Table 2. Humana — Revenue by Segment 2023-2025
Table 3. Humana — Membership and Covered Lives 2023-2025
Table 4. Humana — R&D and Technology Investment 2023-2025
Table 5. Humana — SWOT Analysis
Table 6. Humana — Key Products and Programs 2025
Table 7. Humana — M&A Activity 2020-2025
Table 8. Humana — Key Management 2025
Table 9. Humana — Strategic Priorities 2025-2030
